My Library

University LibraryCatalogue

     
Limit search to items available for borrowing or consultation
Can't find that book? Try BONUS+
 
Look for full text

Search Discovery

Search CARM Centre Catalogue

Search Trove

Add record to RefWorks

Book Cover
PRINTED BOOKS
Author Green, Michael D., 1950-

Title Bendectin and birth defects : the challenges of mass toxic substances litigation / Michael D. Green.

Published Philadelphia : University of Pennsylvania Press, [1996]
©1996

Copies

Location Call No. Status
 UniM Law  KN 39 P6 G1 GREE    AVAILABLE
Physical description xiii, 368 pages ; 24 cm
Bibliography Includes bibliographical references (pages [353]-359) and index.
Contents 1. A Birth Defect Child Is Born -- 2. Locating Bendectin Within the Mass Toxic Landscape -- 3. The Science of Determining Toxic Causation -- 4. The Food and Drug Administration -- 5. The Wm. S. Merrell Company -- 6. A Mother's Quest -- 7. The Mekdeci Case -- 8. The Unraveling of Mekdeci -- 9. The Proliferation of Bendectin Litigation -- 10. Litigating a Multidistrict Case -- 11. The Withdrawal of Bendectin -- 12. Forging a Mass Toxic Substances Trial -- 13. The Settlement and Unsettlement of MDL-486 -- 14. The MDL-486 Trial -- 15. Aggregative Procedure in Mass Toxic Substances Litigation -- 16. The Third Phase of Bendectin Litigation: Oxendine Richardson, and the Individual Trials -- 17. The Legacy of Bendectin for Toxic Causation Law -- 18. The Lessons and Non-Lessons of Bendectin Litigation.
Summary Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabilities would result in precedent-setting litigation. Before it was over, the Benedictin litigation would involve 2,000 claimants over a fifteen-year period. Michael D. Green offers a comprehensive overview of the Benedictin case and highlights many of the key issues in mass toxic substances litigation.
Subject Products liability -- Drugs -- United States.
Toxic torts -- United States.
Complex litigation -- United States.
Bendectin (Trademark) -- Toxicology.
Abnormalities, Human.
ISBN 0812232577 (alk. paper)
0812232577